Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis

Angiotensin receptor blockers (ARB) and angiotensin converting enzyme inhibitors (ACEI) reduce cardiovascular events in the general population. Maintenance hemodialysis (MHD) patients are at high cardiovascular risk but few studies have directly addressed the comparative efficacy of these drugs. MHD disrupts the normally atheroprotective actions of high density lipoprotein (HDL), therefore, we compared ACEI or ARB treatment on HDL functions in MHD.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - March 8, 2018 Category: Nutrition Authors: R. Kaseda, Y. Tsuchida, J.L. Gamboa, J. Zhong, L. Zhang, H. Yang, A. Dikalova, A. Bian, S. Davies, A.F. Fogo, M.F. Linton, N.J. Brown, T.A. Ikizler, V. Kon Source Type: research